c-LEcta

c-LEcta is a global industrial biotechnology company founded in 2004 as a spin-off from the University of Leipzig, specializing in the development, production, and distribution of customized enzyme products and microbial strains. Using its proprietary ENESYZ technology platform — a bioinformatics-based system for targeted enzyme engineering — c-LEcta serves pharmaceutical, food, and industrial customers worldwide. The company maintains a collection of over 5,000 preselected microbial strains and million-gene metagenomic libraries to identify and engineer best-in-class biocatalysts. In 2022, c-LEcta was acquired by Kerry Group for €137 million and now operates as a Kerry Biotechnology Centre in Leipzig.